Glaxosmithkline has no heart scarring history on Clinicaltrials. Adding LL for MF to their new mandate, would be economically smart.

Would love to know who & how many 3rd parties are sitting with Cytodyn. This is all just phenominal.

Heart scarring, also known as myocardial fibrosis, is a condition where damaged heart muscle tissue is replaced with non-functional scar tissue. This can occur after a heart attack, heart failure, or other injuries to the heart.
Causes:
Myocardial infarction (heart attack)
Heart failure
Inflammation of the heart (myocarditis)
Infections
Certain medications
Genetic conditions

https://clinicaltrials.gov/search?cond=myocar...smithkline